Article ; Online: Re-treating bleeding hereditary haemorrhagic telangiectasia with bevacizumab.
The Medical journal of Australia
2013 Volume 199, Issue 10, Page(s) 658
MeSH term(s) | Aged ; Angiogenesis Inhibitors/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Bevacizumab ; Humans ; Male ; Recurrence ; Telangiectasia, Hereditary Hemorrhagic/diagnosis ; Telangiectasia, Hereditary Hemorrhagic/drug therapy |
---|---|
Chemical Substances | Angiogenesis Inhibitors ; Antibodies, Monoclonal, Humanized ; Bevacizumab (2S9ZZM9Q9V) |
Language | English |
Publishing date | 2013-05-01 |
Publishing country | Australia |
Document type | Case Reports ; Letter |
ZDB-ID | 186082-3 |
ISSN | 1326-5377 ; 0025-729X |
ISSN (online) | 1326-5377 |
ISSN | 0025-729X |
DOI | 10.5694/mja13.10260 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.398: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.